정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2431 | Active, not recruiting | A Study of Ad26.COV2.S in Healthy Adults (COVID-19) | Healthy | Biological: Ad26.COV2.S | Phase 1 | Janssen Vaccines & Prevention B.V. | INDUSTRY | 380 | All | 18 Years ~ 65 Years | PRA Health Sciences, Groningen, Netherlands |
| 2430 | Recruiting | A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) | COVID-19 Prevention | Biological: Ad26.COV2.S | Phase 2 | Janssen Vaccines & Prevention B.V. | INDUSTRY | 400 | Female | 18 Years ~ 45 Years | Central Research Associates, Inc., Birmingham, Alabama, United States SEC Clinical Research, Dothan, Alabama, United States University of Southern California, Los Angeles, California, United States Stanford Health Care - Positive Care Clinic, Stanford, California, United States Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States Emory University, Atlanta, Georgia, United States Spectrum Health System, Grand Rapids, Michigan, United States Medpharmics, LLC, Gulfport, Mississippi, United States Meridian Clinical Research, LLC, Grand Island, Nebraska, United States Meridian Clinical Research, LLC, Norfolk, Nebraska, United States Excel Clinical Research, Las Vegas, Nevada, United States Wr-Crcn, Llc, Las Vegas, Nevada, United States Medpharmics, LLC, Albuquerque, New Mexico, United States Columbia University Medical Center, New York, New York, United States Monroe Biomedical Research, Monroe, North Carolina, United States Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States Synexus Clinical Research US, Inc, Columbus, Ohio, United States University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States Tekton Research Inc., Austin, Texas, United States Baylor College of Medicine and Texas Childrens Hospital, Houston, Texas, United States Centex Studies, Inc., Houston, Texas, United States Maximos OB/GYN, League City, Texas, United States Hospital de Clinicas da Universidade Federal De Minas Geraisnas Gerais, Belo Horizonte, Brazil HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Brazil Instituto Do Cancer Do Hospital Pompeia, Caxias do Sul, Brazil Hospital Sao Jose, Criciuma, Brazil Hospital Universitario da UNIMAR, Marilia, Brazil Centro de Estudos e Pesquisas em Molestias Infecciosas, Natal, Brazil Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil Hospital Geral de Nova Iguacu - HGNI DST/AIDS, Rio De Janeiro, Brazil Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil University of Sao Paulo Brazil NICHD CRS, Sao Paulo, Brazil CMPC - Consultoria Medica e Pesquisa Clinica, Sorocaba, Brazil CEMEC - Centro Multidisciplinar de Estudos Clinicos, Sao Bernardo do Campo, Brazil Universidade Municipal de Sao Caetano do Sul, Sao Caetano do Sul, Brazil Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, Sao Paulo, Brazil Ndlovu Elandsdoorn Site, Dennilton, South Africa Shandukani Research Centre, Johannesburg, South Africa Stanza Clinical Research Centre : Mamelodi, Mamelodi East, South Africa Setshaba Research Centre, Soshanguve, South Africa Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa Vaccines and Infectious Diseases Analytics Research Unit (VIDA), Formely RMPRU, Soweto, South Africa |
| 2429 | Recruiting | A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19) | SARS-CoV-2 Infection( COVID-19 ) | Biological: Mesenchymal stem cell Biological: Placebo |
Phase 2 | Rohto Pharmaceutical Co., Ltd. | INDUSTRY | 20 | All | 20 Years | Osaka University Hospital, Suita, Osaka, Japan |
| 2428 | Completed | A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects | Coronavirus Disease 2019 (COVID-19) | Drug: AK119 Drug: Placebo |
Phase 1 | Akesobio Australia Pty Ltd | INDUSTRY | 29 | All | 18 Years ~ 55 Years | Christchurch Clinical Studies Trust, Christchurch, New Zealand |
| 2427 | Recruiting | A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy | B-cell Non Hodgkin Lymphoma | Drug: Anakinra | Phase 2 | Memorial Sloan Kettering Cancer Center | OTHER | 90 | All | 18 Years | Memorial Sloan Kettering Cancer Center, New York, New York, United States |
| 2426 | Completed | A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 | Acute Respiratory Distress Syndrome | Drug: APL-9 Other: Vehicle Control |
Phase 2 | Apellis Pharmaceuticals, Inc. | INDUSTRY | 65 | All | 18 Years | University of California at San Francisco - Fresno, Fresno, California, United States California Pacific Medical Center, San Francisco, California, United States Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States Westchester General Hospital, Miami, Florida, United States Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States Loyola University Medical Center, Maywood, Illinois, United States Lutheran Health Physicians, Fort Wayne, Indiana, United States University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States Norton Women's and Children's Hospital, Louisville, Kentucky, United States Norton Audobon Hospital, Louisville, Kentucky, United States Cambridge Medical Trials, Alexandria, Louisiana, United States Ascension Providence Hospital, Southfield, Michigan, United States Rutgers University - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States University at Buffalo, Buffalo, New York, United States Columbia University, New York, New York, United States Texas A&M College of Medicine - Scott and White, Temple, Texas, United States Hospital Angelina Caron, Campina Grande Do Sul, Parana, Brazil Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil Hospital Sao Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil Hospital Estadual Mario Covas, Santo Andre, Sao Paulo, Brazil CEMEC - Centro Multidisciplinar de Estudos Clinicos LTDA EPP, Sao Bernardo Do Campo, Sao Paulo, Brazil Hospital Alemao Oswaldo Cruz, Sao Paulo, Sao Paulo, Brazil Hospital Santa Marcelina, Sao Paulo, Sao Paulo, Brazil UPECLIN - Unidade de Pesquisa Clinica da Faculdade de Medicina de Botucatu - FMB/UNESP, Botucatu, Sao Paulo, Brazil |
| 2425 | Recruiting | A Study of Auxora in Patients With Critical COVID-19 Pneumonia | Pneumonia | Drug: CM4620-IE (Injectable Emulsion) Drug: Placebo |
Phase 2 | CalciMedica, Inc., Northwestern University | INDUSTRY | 36 | All | 18 Years | Northwestern Memorial Hospital, Chicago, Illinois, United States |
